Barbara Walch-Rückheim
5PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 24, 2026
Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2-dependent manner.Selina Gies, Maike Pohlers, Tanja Tänzer
|Mar 14, 2025
PD-L1+ CD49f+ CD133+ Circulating tumor cells predict outcome of patients with vulvar or cervical cancer after radio- and chemoradiotherapy.Selina Gies, Patrick Melchior, Istvan Molnar
|Oct 30, 2023
Th17 cells target the metabolic miR-142-5p-succinate dehydrogenase subunit C/D (SDHC/SDHD) axis, promoting invasiveness and progression of cervical cancers.Maike Pohlers, Selina Gies, Tanja Taenzer
|Oct 03, 2023
Immune landscape of vulvar cancer patients treated with surgery and adjuvant radiotherapy revealed restricted T cell functionality and increased IL-17 expression associated with cancer relapse.Selina Gies, Patrick Melchior, Russalina Stroeder
|Sep 01, 2021
Chemoradiotherapy-induced increase in Th17 cell frequency in cervical cancer patients is associated with therapy resistance and early relapse.Laura Theobald, Russalina Stroeder, Patrick Melchior
Pageof 1
